|
Mutant p53 as target for improved cancer treatment
| acronym: |
MUTP53 |
| start: |
2004-02-01 |
| end: |
2009-01-31 |
| |
| programme: |
FP6 - Euroopa Liidu 6. raamprogramm |
| sub-programme: |
LIFESCIHEALTH - Eluteadused, tervishoiule suunatud genoomikateadus ja biotehnoloogia |
| instrument: |
IP - Integreeritud projektid |
| call identifier: |
FP6-2002-LIFESCIHEALTH |
| project number: |
502983 |
| duration in months: |
60 |
| partner count: |
15 |
| partner no and role |
partner name |
country |
contact person |
web page |
| 1 |
coordinator |
KAROLINSKA INSTITUTET |
SE |
Klas Wiman |
http://www.ki.se |
| 15 |
partner |
Asper Biotech AS |
EE |
Tonisson Neeme |
http://www.asperbio.com |
|
